ICAM2 and pancreatic neoplasm: Indeed, Liu et al. [175] reported pancreatic tumor cells to be resistant to γδ-T-cells because of the poor binding occurring in absence of ICAM-1 or ICAM-2 at the surface of the cancer cells.